Delivery Order SPE2DB20D1100-SPE2DB25FD6H6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,331.40 to AmerisourceBergen Drug Corp for ALBURX (Human) 5% Vial 500ML on September 8, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The award was placed to AmerisourceBergen Drug Corp's Corporate Office, headquartered in Conshohocken, Pennsylvania, which serves as a primary pharmaceutical...
- The Defense Logistics Agency awarded a $2,700.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Alburx (Human) 25% Vial 100ML, a pharmaceutical product. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 11, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,281.50 by the Defense Logistics Agency on September 18, 2025, with an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price contract calls for the delivery of Albuked-25 vial 100ml to support federal medical procurement needs. The delivery order is classified as a child contract under a larger indefinite delivery contract vehicle, reflecting...
- The Defense Logistics Agency awarded a $1,140.75 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of ALBUKED-25 vials in 100ml quantities. This firm fixed-price contract, with an ultimate completion date of October 10, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be performed at the contractor's facility in...
- The Defense Logistics Agency awarded a $1,131.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of ALBUKED-25 vial 50ML pharmaceutical product. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of August 1, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,368.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of ALBUKED-25 Vial 100ML pharmaceutical product. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,563.00 by the Defense Logistics Agency on July 28, 2025, for the supply of ALBUKED-25 vial 100ML. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award based on open competition. Performance is scheduled for completion by August 18, 2025, with work to be performed at the company's Conshohocken, PA location. This delivery order is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $10,137.08 for Abrysvo vial with diluent syringes. The contract, which carries a firm fixed price structure, was executed on August 27, 2025, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $1,650.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ALBUKED-5 VIAL 250ML, with an ultimate completion date of August 21, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,140.75 to AmerisourceBergen Drug Corp for the supply of ALBUKED-25 VIAL 100ML, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6H6Delivery Order
The Defense Logistics Agency awarded a $2,662.80 delivery order to AmerisourceBergen Drug Corp for ALBURX (Human) 5% Vial 500ML, a pharmaceutical product to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 14, 2025, and was issued on July 24, 2025. The award utilized no set-aside designation, reflecting AmerisourceBergen's qualification to compete in open federal procurement. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a prime vendor for DLA's pharmaceutical supply chain, AmerisourceBergen serves as a critical supplier of medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems globally. The company's extensive federal contract portfolio demonstrates its capacity to fulfill diverse medical procurement requirements across multiple therapeutic domains for Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/24/25 |